Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
ARCA Biopharma Inc
ABIOCurrent price
3.07 USD
-0.03 USD (-0.97%)
Last closed
3.1 USD
Company
www.arcabio.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
47 293 144 USD
Yield for 12 month
+50.49 %
1Y
3Y
5Y
10Y
15Y
ABIO
ARCA biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with heart failure. It is developing Recombinant Nematode Anticoagulant Protein c2, a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. The company has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. ARCA biopharma, Inc. is headquartered in Westminster, Colorado. Address: 10170 Church Ranch Way, Westminster, CO, United States, 80021
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
7 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
+176 000 USD
Current Year
-111 000 USD
Last Year
-114 000 USD
Current Quarter
-19 000 USD
Last Quarter
+153 000 USD
Key Figures ABIO
1 year
3 years
5 years
10 years
EBITDA
-7 968 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-12.67 %
PEG Ratio
–
Return On Equity TTM
-15.87 %
Wall Street Target Price
7 USD
Revenue TTM
–
Book Value
2.42 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.42 USD
Diluted Eps TTM
-0.42 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ABIO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ABIO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:18
Payout Ratio
–
Last Split Date
04.04.2019
Dividend Date
04.04.2019
Stock Valuation ABIO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-1.3579
Price Book MRQ
1.2691
Financials ABIO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ABIO
For 52 weeks
1.56 USD
4.49 USD
50 Day MA
3.44 USD
Shares Short Prior Month
4 139 647
200 Day MA
2.37 USD
Short Ratio
66.06
Shares Short
4 175 393
Short Percent
40.26 %
BeatStart